Cytosorbents (CTSO) Gross Margin (2011 - 2026)
Cytosorbents (CTSO) reported Gross Margin of 69.16% for Q1 2026, down 197.0% on a YoY basis from 71.29% in Q1 2025, and down 6.15% quarter-over-quarter from 73.68% in Q4 2025.
Cytosorbents (CTSO) Gross Margin (2011 - 2026) Analysis & Trends
Cytosorbents has reported Gross Margin for 16 years, with the latest figure at 69.16% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 197.0% year-over-year to 69.16%; the trailing twelve-month figure through Mar 2026 stood at 71.01% (up 245.0% YoY), and the FY2025 full-year result was 71.48%, up 156.0% from the prior year.
- Gross Margin for Q1 2026 stood at 69.16%, down from 73.68% in the prior quarter.
- The five-year high for Gross Margin was 76.46% in Q1 2024, with the low at 44.6% in Q3 2022.
- Historically, Gross Margin has averaged 65.82% across 5 years, with a median of 68.35% in 2024.
- Annual changes were most pronounced in 2022 — Gross Margin plunged 3017 bps — and 2023, when it surged 1904 bps.
- Cytosorbents' Gross Margin stood at 61.31% in 2022, then decreased by 0 bps to 61.27% in 2023, then increased by 12 bps to 68.35% in 2024, then rose by 8 bps to 73.68% in 2025, then retreated by 6 bps to 69.16% in 2026.
- The last three Gross Margin figures came in at 69.16% (Q1 2026), 73.68% (Q4 2025), and 70.28% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 56.20% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 63.29% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 63.83% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 69.46% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 78.01% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 45.22% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 62.95% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 38.53% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 43.89% |
| 10 | Cytosorbents | 28.80 Mn | 24.00 Mn | 6.13 Mn | 69.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.16% |
| Dec 31, 2025 | 73.68% |
| Sep 30, 2025 | 70.28% |
| Jun 30, 2025 | 70.85% |
| Mar 31, 2025 | 71.12% |
| Dec 31, 2024 | 68.35% |
| Sep 30, 2024 | 61.02% |
| Jun 30, 2024 | 73.55% |
| Mar 31, 2024 | 76.46% |
| Dec 31, 2023 | 61.27% |
| Sep 30, 2023 | 63.64% |
| Jun 30, 2023 | 63.89% |
| Mar 31, 2023 | 57.73% |
| Dec 31, 2022 | 61.31% |
| Sep 30, 2022 | 44.60% |
| Jun 30, 2022 | 58.21% |
| Mar 31, 2022 | 73.79% |
| Dec 31, 2021 | 71.04% |
| Sep 30, 2021 | 74.77% |
| Jun 30, 2021 | 77.46% |